Carbapenem-resistant pathogens in US patients hospitalized with respiratory infections

被引：0
|
作者：
Cai, Bin [1 ]
Echols, Roger [2 ]
Rudin, Deborah [1 ]
Corvino, Frank [3 ]
Morgan, Gareth [1 ]
Ariyasu, Mari [4 ]
Sawada, Takuko [4 ]
Nagata, Tsutae [4 ]
机构：
[1] Shionogi Inc, Florham Pk, NJ USA
[2] ID3C, Easton, CT USA
[3] Genesis Res LLC, Hoboken, NJ USA
[4] Shionogi & Co Ltd, Osaka, Japan
来源：
EUROPEAN RESPIRATORY JOURNAL | 2018年 / 52卷
关键词：
D O I：
10.1183/13993003.congress-2018.PA4695
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA4695
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Survey of US wastewater for carbapenem-resistant Enterobacteriaceae
    Hoelle, Jill
    Johnson, James R.
    Johnston, Brian D.
    Kinkle, Brian
    Boczek, Laura
    Ryu, Hodon
    Hayes, Sam
    JOURNAL OF WATER AND HEALTH, 2019, 17 (02) : 219 - 226
  • [32] Impact of carbapenem-resistant Acinetobacter baumannii infections on acute pancreatitis patients
    Wu, Di
    Huang, Yilin
    Ding, Junjie
    Jia, Yan
    Liu, Huanmiao
    Xiao, Jie
    Peng, Jie
    PANCREATOLOGY, 2022, 22 (02) : 194 - 199
  • [33] Risk factors for the acquisition of carbapenem-resistant Escherichia coli among hospitalized patients
    Jeon, Min-Hyok
    Choi, Sang-Ho
    Kwak, Yee Gyung
    Chung, Jin-Won
    Lee, Sang-Oh
    Jeong, Jin-Yong
    Woo, Jun Hee
    Kim, Yang Soo
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2008, 62 (04) : 402 - 406
  • [34] Recent updates in treating carbapenem-resistant infections in patients with hematological malignancies
    Aslan, Abdullah Tarik
    Akova, Murat
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2024,
  • [35] Efficacy and In Vitro Activity of Novel Antibiotics for Infections With Carbapenem-Resistant Gram-Negative Pathogens
    Cruz-Lopez, Flora
    Martinez-Melendez, Adrian
    Morfin-Otero, Rayo
    Rodriguez-Noriega, Eduardo
    Maldonado-Garza, Hector J.
    Garza-Gonzalez, Elvira
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
  • [36] Risk factors for the acquisition of carbapenem-resistant Klebsiella pneumoniae among hospitalized patients
    Kwak, YG
    Choi, SH
    Choo, EJ
    Chung, JW
    Jeong, JY
    Kim, NJ
    Woo, JH
    Ryu, J
    Kim, YS
    MICROBIAL DRUG RESISTANCE, 2005, 11 (02) : 165 - 169
  • [37] Clinical characteristics, risk factors, and outcomes of patients hospitalized in the US military health system with carbapenem-resistant Enterobacteriaceae infection
    Adams, Daniel J.
    Susi, Apryl
    Nylund, Cade M.
    AMERICAN JOURNAL OF INFECTION CONTROL, 2020, 48 (06) : 644 - 649
  • [38] Guidelines for Antibacterial Treatment of Carbapenem-Resistant Enterobacterales Infections
    Park, Se Yoon
    Baek, Yae Jee
    Kim, Jung Ho
    Seong, Hye
    Kim, Bongyoung
    Kim, Yong Chan
    Yoon, Jin Gu
    Heo, Namwoo
    Moon, Song Mi
    Kim, Young Ah
    Song, Joon Young
    Choi, Jun Yong
    Park, Yoon Soo
    INFECTION AND CHEMOTHERAPY, 2024, 56 (03): : 308 - 328
  • [39] Use of meropenem in treating carbapenem-resistant Enterobacteriaceae infections
    Pascale, Renato
    Giannella, Maddalena
    Bartoletti, Michele
    Viale, Pierluigi
    Pea, Federico
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2019, 17 (10) : 819 - 827
  • [40] The role of carbapenem-resistant pathogens in cSSTI and how to manage them
    Del Giacomo, Paola
    Losito, Angela Raffaella
    Tumbarello, Mario
    CURRENT OPINION IN INFECTIOUS DISEASES, 2019, 32 (02) : 113 - 122
12345